Of note, incidence of MTC was extremely low in all of the large cardiovascular outcome trials with no significant increase seen in GLP-1RA-treated individuals, although it should be highlighted that some of the trials did have a family history of MEN-2 as an exclusion criterion
Why patients love Semaglutide: Proven track record and FDA-approved for weight loss Helps reduce appetite and cravings Can support long-term weight management with lifestyle changes Understanding Tirzepatide Tirzepatide is one of the newest medications available and its making a big impact
Contact your GP if you experience significant weakness interfering with daily activities, difficulty performing previously manageable tasks, rapid weight loss exceeding 1 kg weekly consistently, or inability to meet minimum nutritional requirements due to severe appetite suppression
For example, someone who reached goal at 15 mg might discover they maintain well at 12.5 mg
Understanding the established risk factors helps contextualise why someone taking Wegovy might develop shingles, independent of their medication